Presight Capital

Divibank is a financing platform that provides businesses with access to growth capital through innovative financial services software. The platform facilitates connections to accredited financial institutions, offering credit solutions that align repayment with revenue performance, thereby preserving cash flow for users. By leveraging data from digital marketing campaigns, Divibank aims to enhance sales volume while ensuring effective campaign performance. This approach empowers entrepreneurs to expand their sales operations and acquire new customers efficiently.

Needle operates as an AI-driven platform for search and agent creation.

Faro provides inexpensive apparel through re-commerce, collaborating with fashion companies to reduce textile waste and dumping at the manufacturing and consumption levels.

ChemomAb Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on addressing fibrosis-related conditions that present significant unmet medical needs. ChemomAb's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of the soluble protein CCL24, which plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently undergoing clinical development, with a primary emphasis on orphan diseases such as Primary Sclerosing Cholangitis (PSC) and Systemic Sclerosis (SSc). The company is advancing three Phase 2 clinical trials for CM-101 in various fibrotic indications, with data anticipated to be reported in the near future.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.

Standard Bots is a New York-based company that specializes in developing robotics platforms for both industrial and domestic applications. Founded in 2011, the company focuses on creating advanced hardware and software solutions, including the RO1 robot, to enhance automation and productivity across various industries. Standard Bots designs its products to be intuitive and easily integrated into existing workflows, ensuring accessibility for businesses of all sizes. The company manufactures robotic arms and develops comprehensive systems that include software, firmware, electronics, and vision systems, allowing customers to implement affordable and easy-to-setup robotic solutions on their shop floors.

Pantheon Design specializes in creating advanced 3D printing systems aimed at revolutionizing medium-scale manufacturing. The company focuses on developing flexible manufacturing solutions that cater to hardware innovators and integrators. Its printers are designed to deliver end-use quality parts significantly faster and at a lower cost compared to traditional methods. Pantheon Design's technology boasts industry-leading tolerances, superior surface finishes, and mechanical properties, ensuring that clients can produce high-quality products with ease and efficiency. By streamlining the manufacturing process, Pantheon Design addresses the common challenges faced by businesses in the production of parts, ultimately enhancing productivity and reducing costs.

Tern Group is an AI Platform to hire and relocate top healthcare talents globally, faster and cheaper. TERN is a full-stack solution to source and relocate top-tier medical and engineering talent from India, North Africa, South Africa, and Central Asia and the approach ensures a seamless, ethical, and transparent migration process, drastically cutting complexity and shaving costs for healthcare systems.

Duetti is a music fintech company that specializes in providing financial solutions for independent musicians. The company acquires catalog rights from artists and monetizes these assets through data-driven strategies and social media marketing. Duetti aims to facilitate quick access to catalog sales, thereby unlocking new investment opportunities for a diverse range of musicians. By offering data-informed pricing for established tracks, the company enables artists to sell individual tracks or portions of their catalog. Duetti's approach not only supports musicians financially but also helps them achieve their professional and personal goals.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Commons is a company based in Oakland, California, that focuses on enabling individuals to track, reduce, and offset the carbon emissions associated with their purchases. Founded in 2018, it offers a consumer-friendly application that provides practical tools for building a more sustainable lifestyle. Users can view their emissions in real-time, discover strategies for reduction, and access a selection of high-quality carbon offsets. By converting everyday purchases into opportunities for climate action, Commons aims to empower individuals and communities to manage their climate impact effectively and contribute to a more sustainable economy.

Alto Neuroscience is a clinical-stage biopharmaceutical company focused on improving mental health treatment through personalized medicine. By utilizing an AI-enabled biomarker platform, Alto integrates detailed patient data regarding brain activity and behavior to develop effective therapeutics for specific populations. The company aims to transform the traditional trial-and-error approach in psychiatry by matching the appropriate treatment to individual patients, thereby enhancing the effectiveness of interventions. Alto's clinical-stage assets include various products targeting conditions such as depressive disorders and schizophrenia, identified through independent brain-based biomarkers. Through its innovative approach, Alto Neuroscience seeks to redefine psychiatric care at a critical time for mental health.

Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a combination of cell biology and mathematical modeling to cultivate purified animal fat in bioreactors. This innovative approach provides a sustainable and cruelty-free ingredient for the meat alternatives industry, as well as applications in other sectors such as bakery, confectionery, and cosmetics. By focusing on cultivated fat, Hoxton Farms aims to meet the growing demand for ethical and environmentally friendly food products.

Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.

Cleerly is a healthcare company focused on improving the prevention of heart attacks through innovative digital care pathways. It aims to establish a new standard for coronary artery disease by combining advanced clinical science with cutting-edge artificial intelligence. Cleerly's platform offers a non-invasive approach that quantifies and characterizes plaque buildup in coronary arteries, enhancing the understanding of cardiovascular health. By providing actionable clinical insights, the company enables healthcare providers to better identify at-risk patients and implement early treatment strategies. Ultimately, Cleerly's data-driven solutions aspire to deliver significant value to the healthcare system while improving heart health outcomes for individuals susceptible to heart attacks.

Lilo is a leading invest-and-experience platform in Europe focused on fractional property ownership. It enables users to purchase shares in high-end residential properties located in sought-after cities across the continent. The platform provides exclusive access to a curated selection of premium properties, allowing members to own fractions of these assets, with ownership divided into up to eight shares. This model facilitates the assembly of a diverse global property portfolio while alleviating the financial and logistical challenges typically associated with property investment.

Duetti is a music fintech company that specializes in providing financial solutions for independent musicians. The company acquires catalog rights from artists and monetizes these assets through data-driven strategies and social media marketing. Duetti aims to facilitate quick access to catalog sales, thereby unlocking new investment opportunities for a diverse range of musicians. By offering data-informed pricing for established tracks, the company enables artists to sell individual tracks or portions of their catalog. Duetti's approach not only supports musicians financially but also helps them achieve their professional and personal goals.

Bamba is an Android application designed to assist micro-merchants in Africa in managing their businesses using mobile technology. The application provides essential tools that enable merchants to handle customer management, facilitate payments, and access cash advances based on their future cash flow. Additionally, Bamba's software allows users to record stock levels, enhancing their operational efficiency. By offering these comprehensive services, Bamba empowers micro-merchants to streamline their business processes and improve financial management directly from their smartphones.

Bamba Corp. is an online data collection platform based in Nairobi, Kenya, founded in 2012. The company specializes in facilitating data gathering for various sectors, including market research, education, health, government, infrastructure, and retail. Bamba allows organizations to conduct surveys and collect insights from users worldwide through its cloud-based platform, which can be accessed easily via web browsers. This innovative approach addresses the inefficiencies of traditional paper-based data collection methods, which are often costly and time-consuming. Bamba enhances response rates by incentivizing participants with mobile airtime, available in 122 countries. By leveraging data from SMS, web, and social media, Bamba provides businesses with cost-effective and high-quality consumer insights, enabling them to better understand and reach their target markets.

Earth is the creators of soil transformation, an environmentally-friendly alternative to burial and cremation. Over a 30-day process, they gently transform a body into nutrient-rich soil. Families receive a portion of this soil - to scatter or plant - and the remaining soil is sent to conservation land that we acquire, to restore and protect it for future generations. Their experience is carbon neutral, digital-first and underpinned by best-in-class family care. Earth is headquartered in Seattle, Washington and was founded in 2020.

RARIO is a non-fungible token (NFT) marketplace founded in 2021 and based in Singapore. It specializes in officially licensed cricket NFTs, allowing fans to buy, sell, and trade a variety of digital collectibles, including playing cards, video moments, and cricket artifacts. The platform enables users to engage with other cricket enthusiasts, participate in exclusive fan clubs, and take part in quests for rewards, while also offering opportunities to earn real money through trading. By making the digital collectible experience more accessible, RARIO aims to enhance fan engagement within the cricket community.

Rejuveron Life Sciences AG is a biotechnology company based in Zug, Switzerland, founded in 2019. The company focuses on developing and investing in innovative drugs and technologies aimed at promoting healthy aging and extending lifespan. As a fully integrated platform, Rejuveron combines its investment strategies with a commitment to advancing therapies that address age-related conditions, leveraging both scientific research and entrepreneurial initiatives in the life sciences sector.

SmithRx is a San Francisco-based company that designs and manages customized pharmacy benefit plans for employers, aiming to enhance employee guidance and satisfaction. Founded in 2016, SmithRx operates on a modern technology platform that emphasizes transparency, efficiency, and data analytics. The company provides a cost-competitive pharmacy benefit management (PBM) model, featuring a pass-through pricing structure, a unified technology system, and high-quality service assurances. Its in-house team combines expertise from various healthcare and technology sectors, including experience from notable companies, to deliver exceptional support and clinical programs. SmithRx focuses on empowering its clients with maximum flexibility and control over their pharmacy benefits, ultimately helping to reduce drug spending and improve the management of prescription benefits. The company's name reflects its commitment to precision and craftsmanship in the pharmacy benefits industry.

Valoreo is an e-commerce holding company that specializes in acquiring, operating, and scaling successful e-commerce brands primarily in Latin America. The company focuses on brands with excellent customer reviews and proven success as top sellers in niche categories with high-growth potential. By consolidating outstanding startups that offer category-leading products, Valoreo enhances their operations and develops its own brands in-house. This strategy allows Valoreo to help its clients significantly scale their businesses and advance to the next stage of development.

FORME Life is a modular smart home gym and home fitness system for fitness and strength workouts. The company combines advanced linked fitness devices with coaching and personal training provided by real people to provide an immersive experience and improve results for both clients and trainers.

Cloud Paper, Inc. is a manufacturer based in Seattle, Washington, that specializes in producing toilet paper from 100% bamboo, positioning itself as a tree-free paper alternative. Founded in 2019, the company is committed to sustainability, aiming to eliminate deforestation associated with traditional paper products. Cloud Paper's offerings are designed to be super-soft and are packaged using recycled materials, with a focus on avoiding plastic in their packaging. By promoting eco-friendly practices, Cloud Paper seeks to provide consumers with a more sustainable option for personal care products while addressing the environmental impact of conventional paper manufacturing. Products are available for purchase through the company's website.

Nana Delivery is an e-commerce and delivery platform that specializes in providing rapid grocery delivery services. By utilizing a network of dark stores strategically located in urban areas, the company ensures that products are stored close to consumers, which facilitates swift order fulfillment. Nana Delivery focuses exclusively on online orders, allowing for efficient selection, packaging, and dispatch of a wide variety of grocery items. This approach aims to enhance the grocery shopping experience by making it more convenient, affordable, and readily accessible for users.

Denario is a financial software developer focused on enhancing cash flow for small and medium-sized businesses (SMBs) and startups. Its integrated B2B payments platform automates essential financial processes, including the automatic receipt of invoices, payment approvals, and scheduling. This streamlining of monthly accounting tasks allows clients to manage and monitor their financial transactions efficiently and securely in one centralized location. By simplifying payment management, Denario aims to improve the overall financial health of its clients.

Enable Medicine is a biotechnology company based in Menlo Park, California, founded in 2019 by Aaron Mayer and Sunil Bodapati. The company specializes in spatial biology data, offering a cloud-based platform that facilitates the generation, management, and analysis of various biological image formats. Enable Medicine's platform provides end-to-end services, including custom panel development and advanced imaging technology, which support researchers, drug developers, and physicians in creating detailed cellular maps. This comprehensive approach enables users to extract valuable insights from diverse sample types, thereby accelerating the drug discovery process and reducing associated costs.

Koniku Inc. is a neurotechnology company based in Berkeley, California, established in 2015. It specializes in developing co-processors made from biological neurons, which enable computers to detect and analyze odors. The company's primary innovation is the Konikore, a smell processor that has applications in various fields, including healthcare, security, industrial monitoring, and food safety. By capturing volatile organic compounds (VOCs) in environments like bathrooms, Koniku aims to create a data network that can predict disease outcomes before they manifest, utilizing machine learning to analyze the collected data. Additionally, Koniku provides preclinical testing services that replicate the sensitivity of biological systems, facilitating the development of devices that can monitor and map interactions with VOCs in human life.

thirdweb is a developer tool designed to accelerate the creation of web3 applications, including apps, games, tokens, NFTs, marketplaces, and DAOs. Founded in 2020 by Furqan Rydhan and Steven Bartlett, the company is based in San Francisco, California. Its platform offers powerful software development kits (SDKs) that enable developers to easily build web3 apps and deploy both custom and pre-built smart contracts. Additionally, thirdweb provides insights to help users understand their project's performance, making it a comprehensive resource for developers looking to integrate web3 features into their projects.

Peek Travel, Inc. is a travel activities marketplace based in San Francisco, California, specializing in tour operator software that facilitates the discovery and booking of tours and activities across the United States. Founded in 2011, Peek offers a platform that connects customers with a curated selection of experiences, allowing users to easily book activities online. The company empowers operators by providing them with tools to manage and grow their businesses effectively. Peek's website and mobile app serve as marketing channels, generating new customer interest by making thousands of activities accessible and bookable anytime, anywhere. Through its technology, Peek aims to create lasting memories for travelers by connecting them with everyday adventures.

Velocity is a prominent financial solution provider in India, specifically catering to digitally native businesses. Founded in 2020 by Abhiroop Medhekar, Atul Khichariya, and Saurav Swaroop, the company seeks to reshape the landscape of banking and financial services for modern enterprises. Velocity offers a diverse array of financial services, including term loans, revenue-based financing, overdrafts, and payment solutions. It distinguishes itself by providing funding options that do not require equity dilution or personal guarantees, allowing clients to repay loans as a fixed percentage of their future revenues. This innovative approach presents an alternative to traditional venture capital and standard loans, enabling businesses to access necessary funds while maintaining greater control over their financial obligations.

Divibank is a financing platform that provides businesses with access to growth capital through innovative financial services software. The platform facilitates connections to accredited financial institutions, offering credit solutions that align repayment with revenue performance, thereby preserving cash flow for users. By leveraging data from digital marketing campaigns, Divibank aims to enhance sales volume while ensuring effective campaign performance. This approach empowers entrepreneurs to expand their sales operations and acquire new customers efficiently.

Bound is a fintech company that makes FX management easy for every business. The company was founded by Seth Phillips and Daniel Kindler in 2020.

Lindus Health is a clinical research organization focused on delivering comprehensive clinical trial services for health and biotech companies. The company offers a range of solutions, including ethics and IRB submission, trial monitoring, data management, biostatistics, regulatory support, and payer affairs. By utilizing a proprietary software platform, Lindus Health automates various aspects of the clinical trial workflow, which streamlines operations and minimizes manual inefficiencies. This platform also facilitates access to electronic health records, enhancing patient recruitment and clinical data capture. Furthermore, Lindus Health leverages real-world patient data to improve trial design and execution, ultimately aiming to accelerate the clinical trial process while reducing risks and costs associated with trial failures.

Una Brands is a Singapore-based company founded in 2020 that specializes in acquiring and transforming e-commerce brands into prominent market leaders. It focuses on purchasing category-winning brands known for their strong performance, quality products, and positive customer feedback. By leveraging substantial growth capital, Una Brands aims to accelerate the growth of these businesses and enhance their visibility in the market. The company employs advanced data analytics and artificial intelligence to optimize its processes, providing these brands with a competitive advantage. Through its strategic branding services, Una Brands seeks to help e-commerce businesses evolve into globally recognized and enduring household names.

Blackrock Neurotech is a company dedicated to developing advanced neurotechnology platforms designed to record bio-potentials from both the central and peripheral nervous systems for chronic and acute applications. The company's precision electrode technology is pivotal in numerous global innovations related to brain-computer interfaces (BCI) and neural signal processing and stimulation. Blackrock Neurotech aims to assist individuals with disabilities, enabling them to walk, talk, see, hear, and feel by providing the clinical community with innovative tools and expertise to create novel implantable solutions that enhance human lives.

Grounded Foods Co. is a West Hollywood-based company that specializes in producing plant-based cheeses made from cauliflower and hemp seeds. Its product offerings include gruyere style cheese, camembert style cheese, marinated hemp seed feta, and hemp seed cream cheese, all crafted through a proprietary fermentation process. This innovative approach allows the products to closely mimic the flavor and texture of traditional dairy cheese while providing high nutritional value and promoting environmental sustainability. Founded in 2019 by Australian entrepreneurs Veronica Fil, a behavioral economist, and Shaun Quade, an internationally acclaimed chef, the company aims to make dairy-free cheese accessible to a wider audience through both retail and online sales.

Perfect Day, Inc. is a pioneering company based in Emeryville, California, that specializes in producing animal-free dairy products. Founded in 2014, the company creates milk, cheese, yogurt, milk proteins, and ice cream that are nutritionally identical to traditional dairy but are made through a fermentation process using plant-based sugars. This innovative approach allows Perfect Day to deliver products that retain the taste, texture, and nutrition of conventional dairy while eliminating concerns related to food safety, environmental impact, and animal welfare. The company's commitment to sustainability and compassion results in nutrient-dense alternatives that are vegan, free from antibiotics, cholesterol, and lactose, catering to a growing market for healthier and more ethical food options.

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

UpScalio is an eCommerce brand investor and operator that provides financial services to invest in, grow, and buy businesses. It provides funds to digital brands selling on eCommerce marketplaces like Amazon, Myntra, Flipkart and Nykaa and manages key operations for them including multi-marketplace management, digital marketing, branding, logistics, sourcing, finance, and business operations.

Penta is a digital business bank platform designed to help startups and SMEs save time and money on banking. It automates bank accounts and invoices, offers online cashless banking services, and helps to open an online banking account in minutes, enabling consumers to manage their cashflows easily. Penta's mission is to disrupt business banking in Europe and worldwide. It was founded in 2016 and is headquartered in Berlin, Germany.

Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.

TMRW Life Sciences is a technology company focused on improving standards of safety, transparency, and accountability in the management of frozen eggs and embryos within the IVF sector. The company has developed the first automated cryo-management platform specifically designed for this purpose, which integrates a digital chain of custody with robotic storage and monitoring solutions. This innovative approach aims to replace traditional manual methods that have remained largely unchanged over the years, thereby significantly reducing the risk of errors that could have serious consequences. Founded in 2018 by Joshua Abram, Alan Murray, and Dr. Jeffrey Port, TMRW combines expertise in fertility, embryology, cryo-management, automation, software development, and robotics to enhance the specimen management process for clinics, facilitating advancements in IVF technology. The company is headquartered in New York, New York.

Syfe is an investment and savings platform that empowers individuals to build their wealth through a comprehensive range of services. It offers fully managed portfolios, cash management solutions, and self-directed investment options, making it a unique all-in-one wealth management platform in the region. The company is fully licensed for fund management, financial advisory, and brokerage in Singapore, Hong Kong, and Australia. Syfe utilizes a proprietary algorithm to tailor portfolios for each client, optimizing returns while managing risk, thus providing customized and globally diversified investment strategies that align with individual risk profiles. The company has secured funding from notable investors, indicating strong market confidence in its innovative approach to wealth management.

UpScalio is an eCommerce brand investor and operator that provides financial services to invest in, grow, and buy businesses. It provides funds to digital brands selling on eCommerce marketplaces like Amazon, Myntra, Flipkart and Nykaa and manages key operations for them including multi-marketplace management, digital marketing, branding, logistics, sourcing, finance, and business operations.

Umoja Biopharma specializes in innovative immunotherapy aimed at transforming cancer treatment and enhancing patient quality of life. The company focuses on reprogramming T cells within the patient's body to effectively target cancer, including solid tumors and hematological cancers that often have poor responses to conventional therapies. Its proprietary CAR T-cell gene therapy platform is designed to deliver scalable therapeutic regimens tailored to various stages of cancer, enabling medical practitioners to directly and safely attack cancer cells. By harnessing the body's immune response, Umoja Biopharma seeks to improve overall patient outcomes and provide more effective treatment options for those affected by cancer.

Opontia is an e-commerce acquiring company focused on purchasing and growing small businesses across the Middle East and Africa. It specializes in acquiring companies that possess strong home-grown brands and long-term competitive advantages. Opontia aims to simplify the selling process for business owners, ensuring they can receive payment within six weeks of accepting an offer. In addition to facilitating sales, Opontia offers expertise in brand building, product design and launch, logistics, and financing for small and medium enterprises. This comprehensive approach allows Opontia to effectively scale the businesses it acquires while providing a fair and efficient selling experience for owners.

Opontia is an e-commerce acquiring company focused on purchasing and growing small businesses across the Middle East and Africa. It specializes in acquiring companies that possess strong home-grown brands and long-term competitive advantages. Opontia aims to simplify the selling process for business owners, ensuring they can receive payment within six weeks of accepting an offer. In addition to facilitating sales, Opontia offers expertise in brand building, product design and launch, logistics, and financing for small and medium enterprises. This comprehensive approach allows Opontia to effectively scale the businesses it acquires while providing a fair and efficient selling experience for owners.

Blackrock Neurotech is a company dedicated to developing advanced neurotechnology platforms designed to record bio-potentials from both the central and peripheral nervous systems for chronic and acute applications. The company's precision electrode technology is pivotal in numerous global innovations related to brain-computer interfaces (BCI) and neural signal processing and stimulation. Blackrock Neurotech aims to assist individuals with disabilities, enabling them to walk, talk, see, hear, and feel by providing the clinical community with innovative tools and expertise to create novel implantable solutions that enhance human lives.

Una Brands is a Singapore-based company founded in 2020 that specializes in acquiring and transforming e-commerce brands into prominent market leaders. It focuses on purchasing category-winning brands known for their strong performance, quality products, and positive customer feedback. By leveraging substantial growth capital, Una Brands aims to accelerate the growth of these businesses and enhance their visibility in the market. The company employs advanced data analytics and artificial intelligence to optimize its processes, providing these brands with a competitive advantage. Through its strategic branding services, Una Brands seeks to help e-commerce businesses evolve into globally recognized and enduring household names.

Una Brands is a Singapore-based company founded in 2020 that specializes in acquiring and transforming e-commerce brands into prominent market leaders. It focuses on purchasing category-winning brands known for their strong performance, quality products, and positive customer feedback. By leveraging substantial growth capital, Una Brands aims to accelerate the growth of these businesses and enhance their visibility in the market. The company employs advanced data analytics and artificial intelligence to optimize its processes, providing these brands with a competitive advantage. Through its strategic branding services, Una Brands seeks to help e-commerce businesses evolve into globally recognized and enduring household names.

Valoreo is an e-commerce holding company that specializes in acquiring, operating, and scaling successful e-commerce brands primarily in Latin America. The company focuses on brands with excellent customer reviews and proven success as top sellers in niche categories with high-growth potential. By consolidating outstanding startups that offer category-leading products, Valoreo enhances their operations and develops its own brands in-house. This strategy allows Valoreo to help its clients significantly scale their businesses and advance to the next stage of development.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

fortú is the personal finance platform for Latinos and Hispanics

Alto Neuroscience is a clinical-stage biopharmaceutical company focused on improving mental health treatment through personalized medicine. By utilizing an AI-enabled biomarker platform, Alto integrates detailed patient data regarding brain activity and behavior to develop effective therapeutics for specific populations. The company aims to transform the traditional trial-and-error approach in psychiatry by matching the appropriate treatment to individual patients, thereby enhancing the effectiveness of interventions. Alto's clinical-stage assets include various products targeting conditions such as depressive disorders and schizophrenia, identified through independent brain-based biomarkers. Through its innovative approach, Alto Neuroscience seeks to redefine psychiatric care at a critical time for mental health.

Angiex is a biotechnology company focused on developing vascular-targeted biotherapeutics for cancer treatment. Founded by leading scientists, the company specializes in antibody-drug conjugate therapies that address key aspects of endothelial biology, particularly angiogenesis. Angiex's lead product utilizes a novel approach to deliver therapeutic agents directly to the nucleus of tumor cells and to the activated endothelium of tumors and inflamed vessels. This innovative method aims to enhance the efficacy of treatments for various solid tumors, including pancreatic, lung, liver cancers, and glioblastoma multiforme. With intellectual property originating from Beth Israel Deaconess Medical Center, Angiex operates out of LabCentral in Cambridge, positioning itself at the forefront of cancer therapeutics.

Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.

Velocity is a prominent financial solution provider in India, specifically catering to digitally native businesses. Founded in 2020 by Abhiroop Medhekar, Atul Khichariya, and Saurav Swaroop, the company seeks to reshape the landscape of banking and financial services for modern enterprises. Velocity offers a diverse array of financial services, including term loans, revenue-based financing, overdrafts, and payment solutions. It distinguishes itself by providing funding options that do not require equity dilution or personal guarantees, allowing clients to repay loans as a fixed percentage of their future revenues. This innovative approach presents an alternative to traditional venture capital and standard loans, enabling businesses to access necessary funds while maintaining greater control over their financial obligations.

ChemomAb Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on addressing fibrosis-related conditions that present significant unmet medical needs. ChemomAb's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of the soluble protein CCL24, which plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently undergoing clinical development, with a primary emphasis on orphan diseases such as Primary Sclerosing Cholangitis (PSC) and Systemic Sclerosis (SSc). The company is advancing three Phase 2 clinical trials for CM-101 in various fibrotic indications, with data anticipated to be reported in the near future.

ATAI Life Sciences AG is a biotechnology company based in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, the company focuses on developing innovative therapies for mental health disorders, including depression, anxiety, and substance use disorders. ATAI utilizes psychedelic compounds and other therapeutic methods to address these conditions, collaborating with various partners and research institutions to enhance its drug development pipeline. Its clinical-stage product portfolio features therapies such as COMP360 (Psilocybin therapy), PCN-101 (R-ketamine), and others derived from compounds like MDMA and ibogaine. By working with experts in the field, ATAI aims to ensure the efficacy and safety of its treatments. The company has garnered recognition for its contributions to mental health research and has secured partnerships and funding to further its initiatives in transforming mental health care.

Penta is a digital business bank platform designed to help startups and SMEs save time and money on banking. It automates bank accounts and invoices, offers online cashless banking services, and helps to open an online banking account in minutes, enabling consumers to manage their cashflows easily. Penta's mission is to disrupt business banking in Europe and worldwide. It was founded in 2016 and is headquartered in Berlin, Germany.

Valoreo is an e-commerce holding company that specializes in acquiring, operating, and scaling successful e-commerce brands primarily in Latin America. The company focuses on brands with excellent customer reviews and proven success as top sellers in niche categories with high-growth potential. By consolidating outstanding startups that offer category-leading products, Valoreo enhances their operations and develops its own brands in-house. This strategy allows Valoreo to help its clients significantly scale their businesses and advance to the next stage of development.

Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a combination of cell biology and mathematical modeling to cultivate purified animal fat in bioreactors. This innovative approach provides a sustainable and cruelty-free ingredient for the meat alternatives industry, as well as applications in other sectors such as bakery, confectionery, and cosmetics. By focusing on cultivated fat, Hoxton Farms aims to meet the growing demand for ethical and environmentally friendly food products.

NewAmsterdam Pharma, established in 2019 and headquartered in Naarden, the Netherlands, is a late-stage biopharmaceutical company dedicated to improving patient care in cardio-metabolic disease populations. The company's primary focus is the development of transformative therapies, with its lead product, obicetrapib, being a next-generation, oral, low-dose CETP inhibitor designed to lower LDL-C levels more effectively than current treatments, particularly for patients with statin intolerance or Arteriosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally-tolerated statin therapy.

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, with an additional office in Boston, Massachusetts. Founded in 1999, the company specializes in developing precision cancer therapeutics, particularly next-generation immunotherapies. Sensei's proprietary drug discovery platform, ImmunoPhage, focuses on understanding the tumor microenvironment to create novel biologics that target tumor-specific antigens and activate both the innate and adaptive immune systems. The company is working on a range of investigational product candidates, including SNS-101, SNS-102, SNS-103, and SNS-20, which aim to address unmet needs in cancer treatment by selectively disabling immunosuppressive signals or activating immunostimulatory signals within the tumor microenvironment. Through its innovative approach and collaboration with experts in biology, immunology, and oncology, Sensei Biotherapeutics seeks to transform cancer treatment and improve outcomes for patients.

Peptilogics, Inc. is a biotechnology company based in West Mifflin, Pennsylvania, that focuses on developing novel peptide therapeutics to combat multidrug-resistant bacterial infections. Established in 2013, Peptilogics employs a unique computational platform that facilitates drug discovery by exploring new chemical design spaces and ensuring the biological viability and manufacturability of potential therapeutics. The company's lead candidate, PLG0206, is a broad-spectrum anti-infective peptide that has received FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation, targeting prosthetic joint infections, which represent a significant unmet medical need. Peptilogics aims to provide effective solutions to address the challenges posed by resistant bacteria and biofilms, ultimately improving treatment outcomes for patients.

Rational Vaccines is a preclinical stage company focused on developing innovative vaccines to combat herpes simplex virus and its related diseases. The company is dedicated to creating live-attenuated viral immunotherapeutic and prophylactic vaccine candidates that aim to reduce the transmission of the herpes virus and effectively manage symptoms associated with its reactivation. By harnessing rational engineering techniques, Rational Vaccines seeks to revolutionize the treatment, prevention, and diagnosis of herpes infections, ultimately improving the quality of life for those affected by these conditions.

ATAI Life Sciences AG is a biotechnology company based in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, the company focuses on developing innovative therapies for mental health disorders, including depression, anxiety, and substance use disorders. ATAI utilizes psychedelic compounds and other therapeutic methods to address these conditions, collaborating with various partners and research institutions to enhance its drug development pipeline. Its clinical-stage product portfolio features therapies such as COMP360 (Psilocybin therapy), PCN-101 (R-ketamine), and others derived from compounds like MDMA and ibogaine. By working with experts in the field, ATAI aims to ensure the efficacy and safety of its treatments. The company has garnered recognition for its contributions to mental health research and has secured partnerships and funding to further its initiatives in transforming mental health care.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Angiex is a biotechnology company focused on developing vascular-targeted biotherapeutics for cancer treatment. Founded by leading scientists, the company specializes in antibody-drug conjugate therapies that address key aspects of endothelial biology, particularly angiogenesis. Angiex's lead product utilizes a novel approach to deliver therapeutic agents directly to the nucleus of tumor cells and to the activated endothelium of tumors and inflamed vessels. This innovative method aims to enhance the efficacy of treatments for various solid tumors, including pancreatic, lung, liver cancers, and glioblastoma multiforme. With intellectual property originating from Beth Israel Deaconess Medical Center, Angiex operates out of LabCentral in Cambridge, positioning itself at the forefront of cancer therapeutics.

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, with an additional office in Boston, Massachusetts. Founded in 1999, the company specializes in developing precision cancer therapeutics, particularly next-generation immunotherapies. Sensei's proprietary drug discovery platform, ImmunoPhage, focuses on understanding the tumor microenvironment to create novel biologics that target tumor-specific antigens and activate both the innate and adaptive immune systems. The company is working on a range of investigational product candidates, including SNS-101, SNS-102, SNS-103, and SNS-20, which aim to address unmet needs in cancer treatment by selectively disabling immunosuppressive signals or activating immunostimulatory signals within the tumor microenvironment. Through its innovative approach and collaboration with experts in biology, immunology, and oncology, Sensei Biotherapeutics seeks to transform cancer treatment and improve outcomes for patients.

Syfe is an investment and savings platform that empowers individuals to build their wealth through a comprehensive range of services. It offers fully managed portfolios, cash management solutions, and self-directed investment options, making it a unique all-in-one wealth management platform in the region. The company is fully licensed for fund management, financial advisory, and brokerage in Singapore, Hong Kong, and Australia. Syfe utilizes a proprietary algorithm to tailor portfolios for each client, optimizing returns while managing risk, thus providing customized and globally diversified investment strategies that align with individual risk profiles. The company has secured funding from notable investors, indicating strong market confidence in its innovative approach to wealth management.

Cloud Paper, Inc. is a manufacturer based in Seattle, Washington, that specializes in producing toilet paper from 100% bamboo, positioning itself as a tree-free paper alternative. Founded in 2019, the company is committed to sustainability, aiming to eliminate deforestation associated with traditional paper products. Cloud Paper's offerings are designed to be super-soft and are packaged using recycled materials, with a focus on avoiding plastic in their packaging. By promoting eco-friendly practices, Cloud Paper seeks to provide consumers with a more sustainable option for personal care products while addressing the environmental impact of conventional paper manufacturing. Products are available for purchase through the company's website.

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Sorare is a Paris-based company that operates a global fantasy football game, allowing users to manage soccer teams using official digital collectible cards. Founded in December 2018, Sorare's platform utilizes blockchain technology to facilitate the trading of non-fungible tokens (NFTs), making it possible for fans to collect, buy, and sell virtual player cards. The platform aims to make cryptocurrency engaging and accessible through the lens of fantasy football. In December 2020, Sorare reported sales of $1.8 million in digital cards, highlighting its growing popularity in the realm of sports collectibles and online gaming.

Penta is a digital business bank platform designed to help startups and SMEs save time and money on banking. It automates bank accounts and invoices, offers online cashless banking services, and helps to open an online banking account in minutes, enabling consumers to manage their cashflows easily. Penta's mission is to disrupt business banking in Europe and worldwide. It was founded in 2016 and is headquartered in Berlin, Germany.

Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.

AbCellera is a biotechnology company specializing in antibody discovery and development. It uses an integrated platform combining proprietary hardware, software, tools, and advanced data science to efficiently identify and develop optimal antibodies for clinical use. The company partners with both emerging biotechs and established pharmaceutical companies, leveraging its expertise to accelerate the drug development process and improve patient outcomes.

COMPASS Pathways is a mental health care company based in Cheshire, United Kingdom, with operations in the United States. The company is focused on developing innovative therapies for treatment-resistant depression (TRD) using its proprietary psilocybin formulation, COMP360. Currently undergoing Phase IIb clinical trials, COMP360 aims to provide a new treatment option for patients who have not responded to traditional depression therapies. COMPASS Pathways emphasizes the combination of psilocybin-assisted therapy with psychological support to enhance treatment efficacy. The company is committed to addressing the significant unmet needs in mental health care by advancing evidence-based solutions for those suffering from mental health challenges.

AbCellera is a biotechnology company specializing in antibody discovery and development. It uses an integrated platform combining proprietary hardware, software, tools, and advanced data science to efficiently identify and develop optimal antibodies for clinical use. The company partners with both emerging biotechs and established pharmaceutical companies, leveraging its expertise to accelerate the drug development process and improve patient outcomes.

EnClear Therapies, Inc. is a life sciences company based in Newburyport, Massachusetts, focused on developing device-based therapies for neurodegenerative diseases. The company specializes in the delivery and monitoring of cerebrospinal fluid (CSF) and has created a proprietary therapeutic platform aimed at removing toxic proteins from the CSF. EnClear's products are primarily designed to improve the lives of patients suffering from conditions such as Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP). By providing innovative solutions in the treatment of these neurological diseases, EnClear Therapies aims to help halt disease progression and extend patient lifespans.

Unmind Ltd is a mental health platform based in London, United Kingdom, specializing in solutions for workplace well-being. Founded in 2016, Unmind provides clinically-backed tools and training designed to foster healthier and happier organizational cultures. The platform offers a range of learning and development programs that empower employees to assess and improve their mental health. By utilizing aggregated and anonymized insights, Unmind enables organizations to drive positive cultural change and understand the overall well-being of their workforce. Its approach aims to create a proactive environment where individuals can enhance their mental health and contribute to a supportive workplace atmosphere.

Habitas is an experience-driven hospitality company that operates a global membership community centered around clubs and lifestyle hotels. Its locations include clubhouses in New York City and Los Angeles, along with a hotel in Tulum, Mexico. Additional properties are being developed in Malibu, the Bahamas, and Namibia. The company focuses on creating spaces that foster connection and community through events that celebrate shared interests such as music, food, and art. Additionally, Habitas is involved in charitable initiatives, including a program called RISE in Uganda, which underscores its commitment to social impact.

General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

Starship is a financial technology company based in New York City, established in 2016. It focuses on creating a mobile health savings account (HSA) platform that integrates savings, investing, and health-tracking tools. The application allows users to conveniently manage their health savings through automated investing in index funds, streamlined reimbursements, and a user-friendly mobile interface. Additionally, it offers features such as receipt management, card management, and family account oversight, facilitating tax-free healthcare expenses and promoting financial wellness. Starship aims to simplify the process of saving and investing for healthcare needs, making it accessible and efficient for users.

ChemomAb Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on addressing fibrosis-related conditions that present significant unmet medical needs. ChemomAb's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of the soluble protein CCL24, which plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently undergoing clinical development, with a primary emphasis on orphan diseases such as Primary Sclerosing Cholangitis (PSC) and Systemic Sclerosis (SSc). The company is advancing three Phase 2 clinical trials for CM-101 in various fibrotic indications, with data anticipated to be reported in the near future.

Karma Biotechnologies, Inc. is a Los Angeles-based startup focused on developing therapies for autoimmune diseases, allergies, and food sensitivities. Founded in 2019, the company offers Xavines, a precision immunotherapy platform designed to address the critical need for antigen-specific therapies that target only the rogue immune cells responsible for these conditions. Unlike traditional treatments that rely on general immune suppression, Karma Biotechnologies aims to create tolerogenic immunotherapies that promote antigen-specific immune tolerance in vivo. By leveraging its expertise in immunology and lipid nanoparticle engineering, the company seeks to provide innovative solutions that enhance the treatment landscape for autoimmune diseases and related disorders.

Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at treating age-related diseases. The company specializes in novel therapeutics that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related health issues. By promoting the clearance of these cells, Deciduous Therapeutics seeks to enhance healthspan and potentially improve the quality of life for individuals experiencing the effects of aging. The company is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, who has founded multiple biotech ventures.

EnClear Therapies, Inc. is a life sciences company based in Newburyport, Massachusetts, focused on developing device-based therapies for neurodegenerative diseases. The company specializes in the delivery and monitoring of cerebrospinal fluid (CSF) and has created a proprietary therapeutic platform aimed at removing toxic proteins from the CSF. EnClear's products are primarily designed to improve the lives of patients suffering from conditions such as Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP). By providing innovative solutions in the treatment of these neurological diseases, EnClear Therapies aims to help halt disease progression and extend patient lifespans.